NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Keywords

Affiliated Institutions

• Université Paris Cité FR
• German Rheumatism Research Centre DE
• Assistance Publique – Hôpitaux de Paris FR
• University Hospital Heidelberg DE
• University Hospital of Bern CH
• Humanitas University IT
• Newcastle University GB
• Helmholtz Zentrum München DE
• Universität Hamburg DE
• Istituti di Ricovero e Cura a Carattere Scientifico IT
• University Children's Hospital Tübingen DE
• National Yang Ming University Hospital TW
• The University of Texas MD Anderson Cancer Center US
• University of Turin IT
• University of Cologne DE
• Kindai University JP
• DKFZ-ZMBH Alliance DE
• Icahn School of Medicine at Mount Sinai US
• Max Planck Institute of Biochemistry DE
• Addenbrooke's Hospital GB
• Heinrich Heine University Düsseldorf DE
• Massachusetts General Hospital US
• German Cancer Research Center DE
• National Yang Ming Chiao Tung University TW
• Imperial College London GB
• Universitat de Barcelona ES
• Memorial Sloan Kettering Cancer Center US
• Hôpital Beaujon FR
• Goethe University Frankfurt DE
• University of Tübingen DE
• University of Zurich CH
• University of Cambridge GB
• Consorci Institut D'Investigacions Biomediques August Pi I Sunyer ES
• Hammersmith Hospital GB
• University Medical Center Hamburg-Eppendorf DE
• Wellcome/MRC Institute of Metabolic Science GB
• Weizmann Institute of Science IL
• Institute of Oncology Research CH
• Université Grenoble Alpes FR
• Délégation Paris 7 FR
• Medical University of Vienna AT
• University Medical Center of the Johannes Gutenberg University Mainz DE
• Cambridge University Hospitals NHS Foundation Trust GB
• University Hospital of Zurich CH
• Johannes Gutenberg University Mainz DE
• Spanish National Cancer Research Centre ES
• Klinikum Klagenfurt AT
• University Medical Centre Mannheim DE
• University Hospital Frankfurt DE
• University of Florence IT
• Heidelberg University DE
• Medizinische Hochschule Hannover DE

Related Publications